KemPharm Inc (OTCQB:KMPH)

0.435
Delayed Data
As of Aug 07
 +0.0167 / +4.00%
Today’s Change
0.12
Today|||52-Week Range
1.37
+14.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization84.0K175.0K336.0K324.0K
 
 
 
 
 
 
Operating ExpensesGross Income-84.0K-175.0K-336.0K-324.0K
 
 
 
 
 
General Expenses22.7M34.3M33.0M53.9M
 
 
 
 
 
Research And Development13.9M20.5M20.6M41.8M
 
 
 
 
 
Total Operating Expenses22.8M34.5M33.4M54.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.8M-34.5M-33.4M-54.3M
 
 
 
 
 
Extraordinary Credit0.0032.5M0.006.0M
 
 
 
Extraordinary Charge-27.3M-7.8M-3.1M-1.6M
 
 
 
 
 
Interest Expense On Debt4.6M7.1M7.3M7.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.6M-16.5M-43.4M-56.6M
 
 
 
 
 
Income Taxes-26.0K-15.0K-43.0K-126.0K
 
 
 
 
 
Net Income-54.7M-16.5M-43.4M-56.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.4M14.6M14.7M17.9M
 
 
 
 
 
Shares To Calculate EPS Diluted7.4M14.6M14.7M17.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.42-$1.13-$2.96-$3.15
 
 
 
 
 
EPS Diluted-$7.42-$1.13-$2.96-$3.15